Indeed, prior studies from our group have demonstrated that the inhibition of CA9 and CA12 can block cell cycle progression and sensitize adult GBM cells to the treatment of radio- (in vitro) and chemotherapy (in vitro and in vivo) [20]. Here, CA9 is linked to glioblastoma.